White Guide and Orange Guide Formatting Project - Pfizer

More documents

Recommendations

Info

Orange Guide – Chapter 8: Privacy: Protecting Personal Information Chapter 8: PRIVACY: PROTECTING PERSONAL INFORMATION CONTENTS Privacy: Protecting Personal Information Privacy ............................................................................................................................................................................. 3 Patients’ Privacy and Personal Information .................................................................................................................. 3 Key Points to Ensure Compliance ........................................................................................................................ 4 Laws Protecting Personal Data ..................................................................................................................................... 5 Business Associate Agreements and Confidentiality Agreements ............................................................................. 5 State and Other Privacy Laws ............................................................................................................................... 7 Steps to Protect Patient Privacy .................................................................................................................................... 7 Avoid Intentional and Inadvertent Disclosure of Sensitive Personal Information ............................................. 7 Seek Only De-Identified Data .............................................................................................................................. 8 Obtain Patient Consent (via Signed Authorization) Where Appropriate .......................................................... 8 Mentorships and Preceptorships ......................................................................................................................... 9 Handling Patients' Personal Data ................................................................................................................................ 10 Pfizer-Sponsored Third Party Communications to Patients............................................................................. 10 Consumer Health Fairs and Screenings ............................................................................................................. 11 Securing Consent and Personal Information from Consumers ................................................................................. 12 Handling HCP Personal Data ....................................................................................................................................... 13 Restricting Access to Personal Information to a “Need to Know” Basis .......................................................... 13 Proper Use of HCP Prescriber Data .................................................................................................................... 14 134 Rev. 09/12 Page 1 of 18
Orange Guide – Chapter 8: Privacy: Protecting Personal Information Providing Your Personal Information When Required By Vendor Credentialing Processes ................................... 15 Corporate Policies on Your Responsibility for Safeguarding Personal Information ........................................ 16 FOR MORE INFORMATION ........................................................................................................................................ 17 135 Rev. 09/12 Page 2 of 18
Page 1 and 2:
Dear Colleagues: Pfizer Inc 235 Eas
Page 3 and 4:
To expand the bookmarks for a chapt
Page 5 and 6:
Orange Guide - Chapter 1: Overview
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Foreign Corrupt Practices Act Orang
Page 17 and 18:
Pfizer’s Corporate Integrity Agre
Page 19 and 20:
Page 21 and 22:
Orange Guide - Chapter 2: Detailing
Page 23 and 24:
Key Points to Ensure Compliance Ora
Page 25 and 26:
Page 27 and 28:
Communicating Formulary Status Mail
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Hospital Protocols Comparative Clai
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Interacting with RMRS Colleagues Or
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Detailing at Journal Club Meetings
Page 49 and 50:
Orange Guide - Chapter 3: Support o
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Medical Education Grants Overview O
Page 57 and 58:
International Grant Activity Orange
Page 59 and 60:
Page 61 and 62:
“Not-for-Profit” Defined Orange
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Information on Pfizer’s External
Page 69 and 70:
Overview Orange Guide - Chapter 3:
Page 71 and 72:
Awards, Scholarships and Fellowship
Page 73 and 74:
Page 75 and 76:
Orange Guide - Chapter 4: Federal E
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Promotional Activities Orange Guide
Page 83 and 84:
Page 85 and 86:
Speaker Program Meals Part-Time VA
Page 87 and 88: Orange Guide - Chapter 4: Federal E
Page 101 and 102: Orange Guide - Chapter 5: Interacti
Page 115 and 116: Discussing Payer Rebates Medical Ac
Page 119 and 120: Orange Guide - Chapter 6: Clinical
Page 127 and 128: Orange Guide - Chapter 7: P&T Commi
Page 131 and 132: Questions From a P&T Committee Memb
Page 137: Orange Guide - Chapter 7: P&T Commi
Page 141 and 142: Orange Guide - Chapter 8: Privacy:
Page 145 and 146: Seek Only De-Identified Data Orange
Page 147 and 148: Consent Forms and Mentorships Orang
Page 149 and 150: REMEMBER Orange Guide - Chapter 8:
Page 151 and 152: Proper Use of HCP Prescriber Data O
Page 157 and 158: Orange Guide - Chapter 9: Speaker P
Page 161 and 162: Speaker Selection Scheduling Issues
Page 163 and 164: Use of Pfizer Approved Speaker Slid
Page 169 and 170: Providing In-Office Meals to Office
Page 171 and 172: U.S. HCP Payment Disclosure Policy
Page 175 and 176: Closeouts Orange Guide - Chapter 9:
Page 179 and 180: Physical Separation of Speaker Prog
Page 181 and 182: Chapter 10: STARTERS CONTENTS Start
Page 183 and 184: Key Points to Ensure Compliance Ora
Page 185 and 186: Orange Guide - Chapter 10: Starters
Page 187 and 188: Inclusion of Materials with Starter
Page 189 and 190:
Orange Guide - Chapter 10: Starters
Page 191 and 192:
Distribution of Starters to Colleag
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Orange Guide - Chapter 11: Patient
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
A special note about Medicare Part
Page 207 and 208:
Refer any questions to your team at
Page 209 and 210:
Chapter 12: CONTRACTING Introductio
Page 211 and 212:
Orange Guide - Chapter 12: Contract
Page 213 and 214:
Orange Guide - Chapter 12: Contract
Page 215 and 216:
Key Points to Ensure Compliance Ora
Page 217 and 218:
Chapter 13: HEALTH SCREENINGS Intro
Page 219 and 220:
Orange Guide - Chapter 13: Health S
Page 221 and 222:
If organized by Pfizer: Orange Guid
Page 223 and 224:
Orange Guide - Chapter 13: Health S
Page 225 and 226:
Orange Guide - Chapter 14: CGC Tool
Page 227 and 228:
Orange Guide - Chapter 14: CGC Tool
Page 229 and 230:
Discussing Pfizer Products While Me
Page 231 and 232:
Orange Guide - Chapter 15: Non-Reba
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Orange Guide - Chapter 16: Consumer
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Providing Food to Consumers at a Di
Page 245 and 246:
Page 247 and 248:
Content of Consumer Slide Decks Att
Page 249 and 250:
Adverse Events Orange Guide - Chapt
Page 251 and 252:
Orange Guide - Chapter 17: State La
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
California Orange Guide - Chapter 1
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Educational Items Orange Guide - Ch
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Orange Guide - Chapter 18: Meals, E
Page 291 and 292:
Page 293 and 294:
Meals to HCPs Orange Guide - Chapte
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Orange Guide - Chapter 19: Sales Ac
Page 313 and 314:
Pricing Considerations Orange Guide
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321:
show all

White Guide and Orange Guide Formatting Project - Pfizer

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?